Cargando…
Serum Adenosine Deaminase Level is High But Not Related with Disease Activity Parameters in Patients with Rheumatoid Arthritis
Serum adenosine deaminase (ADA) has been previously proposed to predict disease activity in patients with rheumatoid arthritis (RA). The aim of this study was to investigate the level of serum ADA, and the relationship between ADA and disease activity markers, in a group of patients with RA. A hundr...
Autores principales: | Demir, Gülseren, Borman, Pınar, Ayhan, Figen, Özgün, Tuba, Kaygısız, Ferda, Yilmez, Gulsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166793/ https://www.ncbi.nlm.nih.gov/pubmed/25279018 http://dx.doi.org/10.2174/1874312901408010024 |
Ejemplares similares
-
LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
por: Borman, Pinar, et al.
Publicado: (2014) -
Foot Problems in a Group of Patients with Rheumatoid Arthritis: An Unmet Need for Foot Care
por: Borman, Pinar, et al.
Publicado: (2012) -
Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate
por: Salesi, Mansour, et al.
Publicado: (2012) -
Quercetin mitigates rheumatoid arthritis by inhibiting adenosine deaminase in rats
por: El-Said, Karim Samy, et al.
Publicado: (2022) -
Serum adenosine deaminase activity in cutaneous anthrax
por: Sunnetcioglu, Mahmut, et al.
Publicado: (2014)